Last reviewed · How we verify
NCT07251387
Muscle Synergies in Pain and Pain Anticipation
NA trial testing Pain expectation conditioning in Pain in 34 participants. Not yet recruiting.
1 February 2026
Quick facts
| Lead sponsor | Universite de Picardie Jules Verne |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 34 |
| Start date | 1 January 2026 |
| Primary completion | 1 February 2026 |
| Estimated completion | 1 April 2026 |
| Sites | 2 locations across France, Canada |
Drugs / interventions tested
- Pain expectation conditioning
- Gait assesment
Conditions studied
- Pain — all drugs for Pain →
- Nocebo Effect — all drugs for Nocebo Effect →
- Pain Anticipation — all drugs for Pain Anticipation →
Sponsor
Universite de Picardie Jules Verne
Who can join
Adults 18 to 35, any sex, with Pain or Nocebo Effect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates how the anticipation of pain affects muscle synergies. Two groups will be compared: an experimental group, who first experience actual pain from capsaicin cream and are then presented with a harmless cream deceptively labeled as capsaicin, against a control group, who are presented with a harmless cream labeled as potentially painful, without any prior painful experience. The changes in muscle synergies will be measured during walking tasks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07251387
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pain expectation conditioning
Trials testing the same drug.
- NCT06929559 — Muscular Synergies and Behavioral Adaptations of Gait in Pain Anticipation (SYAMAPP) · NA · not yet recruiting
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other Universite de Picardie Jules Verne trials
Trials by the same sponsor.
- NCT06929559 — Muscular Synergies and Behavioral Adaptations of Gait in Pain Anticipation (SYAMAPP) · NA · not yet recruiting
- NCT06669767 — Behavioral Indicators of Pain Representation · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07251387 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universite de Picardie Jules Verne
- Last refreshed: 26 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07251387.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing